Apply to trial NCT07474220

A few quick questions so the study team can decide if you might be a fit.

Recruiting

Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease

This study aims to investigate the expression level of SLC25A48, a mitochondrial choline transporter, in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease, and to analyze its correlation with inflammatory markers and choline metabolic byproducts.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening